"Misperceived risk among female adolescents: social and psychological factors associated with sexual risk accuracy." Health psychology : official journal of the Division of Health Psychology, American Psychological Association 22, no. 5 (2003): 523-32. Abstract
"Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states." Journal of acquired immune deficiency syndromes (1999) 33, no. 5 (2003): 608-13. Abstract
"Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences." Journal of acquired immune deficiency syndromes (1999) 31 Suppl 3 (2002): S98-102. Abstract
"Pregnant adolescents at risk: sexual behaviors and sexually transmitted disease prevalence." American journal of obstetrics and gynecology 188, no. 1 (2003): 63-70. Abstract
"Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial." The American journal of cardiology 91, no. 2 (2003): 137-42. Abstract
"Social class and mortality in older women." Journal of clinical epidemiology 55, no. 10 (2002): 952-8. Abstract
"The Perinatal Guidelines Evaluation Project HIV and Pregnancy Study: overview and cohort description." Public health reports (Washington, D.C. : 1974) 117, no. 2 (2002): 137-47. Abstract
"Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project." Journal of acquired immune deficiency syndromes (1999) 30, no. 3 (2002): 311-5. Abstract
"Women's health research: policy and practice." IRB 15, no. 4 (1993): 1-7.
"Adapting an Evidence-Based Intervention Targeting HIV-Infected Prisoners in Malaysia." AIDS research and treatment 2011 (2011): 131045. Abstract
"Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence." The American journal of drug and alcohol abuse 33, no. 5 (2007): 643-54. Abstract
"Successfully integrating an HIV risk reduction intervention into a community-based substance abuse treatment program." The American journal of drug and alcohol abuse 33, no. 1 (2007): 109-20. Abstract
"Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy." Journal of substance abuse treatment 31, no. 2 (2006): 163-71. Abstract
"Experts outline ways to decrease the decade-long yearly rate of 40,000 new HIV infections in the US." AIDS and behavior 10, no. 1 (2006): 105-14. Abstract
"Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment." Journal of psychoactive drugs 35, no. 2 (2003): 209-18. Abstract
"A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients." Journal of addictive diseases 22, no. 2 (2003): 49-61. Abstract
"Medication Persistence of HIV-infected Drug Users on Directly Administered Antiretroviral Therapy." AIDS and behavior (2011). Abstract
"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S33-8. Abstract
"Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence." The American journal of drug and alcohol abuse 37, no. 1 (2011): 1-11. Abstract
"HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners." The American journal of drug and alcohol abuse 37, no. 1 (2011): 12-21. Abstract
"Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia." The American journal of drug and alcohol abuse 36, no. 1 (2010): 31-8. Abstract
"A prospective controlled trial of routine opt-out HIV testing in a men's jail." PloS one 4, no. 11 (2009): e8056. Abstract
"Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial." PloS one 4, no. 11 (2009): e7648. Abstract
"Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV." Journal of the International AIDS Society 12 (2009): 14. Abstract
"Strategies for primary HIV prevention that target behavioral change." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 45 Suppl 4 (2007): S300-307. Abstract
"Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial." Journal of acquired immune deficiency syndromes (1999) 46, no. 5 (2007): 555-63. Abstract
"Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy." AIDS and behavior 12, no. 2 (2008): 284-93. Abstract
"Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases." The American journal of drug and alcohol abuse 33, no. 6 (2007): 869-74. Abstract
"Observations on implementing routine HIV testing in jails." AIDS patient care and STDs 21, no. 10 (2007): 715-6; author reply 717.
"Antiretroviral treatment regimen outcomes among HIV-infected prisoners." HIV clinical trials 8, no. 4 (2007): 205-12. Abstract
"HIV control efforts should directly address incarceration." The Lancet infectious diseases 7, no. 9 (2007): 568-9.
"Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 45, no. 6 (2007): 770-8. Abstract
"HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications." The International journal on drug policy 18, no. 4 (2007): 326-8. Abstract
"Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services." The International journal on drug policy 18, no. 4 (2007): 306-12. Abstract
"Attitudes toward and beliefs about prenatal HIV testing policies and mandatory HIV testing of newborns among drug users." AIDS & public policy journal 20, no. 3-4 (2005): 74-91. Abstract
"Clinical care of the HIV-infected drug user." Infectious disease clinics of North America 21, no. 1 (2007): 149-79, ix. Abstract
"Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence." Journal of substance abuse treatment 32, no. 4 (2007): 399-409. Abstract
"HIV testing in correctional institutions: evaluating existing strategies, setting new standards." AIDS & public policy journal 20, no. 1-2 (2005): 3-24. Abstract
"Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S48-53. Abstract
"The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S178-83. Abstract
"Buprenorphine and HIV primary care: new opportunities for integrated treatment." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S169-72. Abstract
"Randomized, controlled trials of directly administered antiretroviral therapy for HIV-infected patients: questions about study population and analytical approach." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43, no. 9 (2006): 1221-2; author reply 1222-3.
"Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice." Journal of acquired immune deficiency syndromes (1999) 41, no. 5 (2006): 563-72. Abstract
"Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir." AIDS (London, England) 20, no. 5 (2006): 783-4.
"Models for integrating buprenorphine therapy into the primary HIV care setting." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 42, no. 5 (2006): 716-21. Abstract
"Managing HIV/AIDS in correctional settings." Current HIV/AIDS reports 2, no. 4 (2005): 165-70. Abstract
"Adherence to hepatitis B virus vaccination at syringe exchange sites." Journal of urban health : bulletin of the New York Academy of Medicine 82, no. 1 (2005): 151-61. Abstract
"Cost-effectiveness of HIV screening for incarcerated pregnant women." Journal of acquired immune deficiency syndromes (1999) 38, no. 2 (2005): 163-73. Abstract
